Erratum: A combination of inhibitors of glycolysis, glutaminolysis and fatty acid synthesis decrease the expression of chemokines in human colon cancer cells.

[This corrects the article DOI: 10.3892/ol.2019.

A combination of inhibitors of glycolysis, glutaminolysis and fatty acid synthesis decrease the expression of chemokines in human colon cancer cells.

Lonidamine, 6-Diazo-5-oxo-L-norleucine (DON) and orlistat are well known inhibitors of glycolysis, glutaminolysis and of fatty acid synthesis, respectively. Although their antitumor effects have been explored in detail, the potential inhibition of the malignant metabolic phenotype and its influence on the expression of chemokines and growth factors involved in colon cancer, have not been previously reported to the best of our knowledge. In the present study, dose-response curves with orlistat, lonidamine or DON were generated from cell viability assays conducted in SW480 colon cancer cells.